ATryn
Sign in to savethumb|Angora goat at the Texas State Fair.
In the Vinony graph
Vinony's link graph records 4 inbound references to ATryn, and connects out to European Union, Massachusetts and digital object identifier.
It sits within the topics Anticoagulants, Genetic engineering and Goats.
Vinony links it to 5 Wikipedia language editions.
~2 min read
Encyclopedic overview
3 sectionsContents
- References
- Further reading
- External links
thumb|Angora goat at the Texas State Fair.
ATryn is the brand name of the anticoagulant antithrombin manufactured by the Massachusetts-based U.S. company rEVO Biologics (formerly known as GTC Biotherapeutics). It is made from the milk of goats that have been genetically modified to produce human antithrombin, a plasma protein with anticoagulant properties. Microinjection was used to insert human antithrombin genes into the cell nucleus of their embryos. ATryn is the first medicine produced using genetically engineered animals. GTC states that one genetically modified goat can produce the same amount of antithrombin in a year as 90,000 blood donations. GTC chose goats for the process because they reproduce more rapidly than cattle and produce more protein than rabbits or mice.
Excerpted from Wikipedia’s “ATryn” article, available under the CC BY-SA 4.0 licence.